| 12391755 |
Methods of use for anti-ILT2 antibodies |
Ilana MANDEL, Tsuri Peretz, Dana HAVES ZIV, Ilana Goldshtein, Anna FRIDMAN-DROR +4 more |
2025-08-19 |
| 12252547 |
Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same |
Mira Peled Kamar, Galit Denkberg, Yoram Reiter, Ilan Beer, Keren Sinik +4 more |
2025-03-18 |
| 12139534 |
Methods and compositions for decreasing soluble immune receptor CD28 |
Motti HAKIM, Dana HAVES ZIV, Edna MEILIN, Yair SAPIR, Avidor Shulman +2 more |
2024-11-12 |
| 12071479 |
Antibodies against ILT2 and use thereof |
Ilana MANDEL, Tsuri Peretz, Dana HAVES ZIV, Ilana Goldshtein, Anna FRIDMAN-DROR +4 more |
2024-08-27 |
| 11485785 |
Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof |
Aya Jakobovits, Orit Foord, Daulet Kadyl Satpayev, Mira Peled Kamar, Galit Denkberg +7 more |
2022-11-01 |
| 11236162 |
Antibodies against ILT2 |
Ilana MANDEL, Tsuri Peretz, Dana HAVES ZIV, Ilana Goldshtein, Anna FRIDMAN-DROR +4 more |
2022-02-01 |
| 11001642 |
Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same |
Mira Peled Kamar, Galit Denkberg, Yoram Reiter, Ilan Beer, Keren Sinik +4 more |
2021-05-11 |